A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
A Phase I/II Study of MCLA-128, a Full Length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients With Solid Tumors (eNRGy)
Sponsor: Partner Therapeutics, Inc.
This PHASE2 trial investigates NRG1 Fusion and NSCLC Harboring NRG1 Fusion and is currently ongoing. Partner Therapeutics, Inc. leads this study, which shows 25 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
25 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting PHASE2
-
May 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE2
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting PHASE2
-
Mar 2025 — Apr 2025 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2025 — Mar 2025 [monthly]
Recruiting PHASE2
▶ Show 20 earlier versions
-
Nov 2024 — Jan 2025 [monthly]
Recruiting PHASE2
-
Sep 2024 — Nov 2024 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Feb 2024 — Jul 2024 [monthly]
Recruiting PHASE2
-
Jan 2023 — Feb 2024 [monthly]
Recruiting PHASE2
-
Sep 2022 — Jan 2023 [monthly]
Recruiting PHASE2
Phase: PHASE1_PHASE2 → PHASE2
-
Feb 2021 — Sep 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2020 — Nov 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2020 — Aug 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2020 — Jun 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2019 — Feb 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE1_PHASE2
Status: Unknown Status → Recruiting
-
Apr 2019 — Sep 2019 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Partner Therapeutics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .